- •The influence of sex on adverse events in MINOCA remains unclear.
- •Our meta-analysis of >28,000 MINOCA patients showed women had more MACE than men (10.1% vs. 9.1%).
- •The adverse events in women were driven only by higher incidence of stroke in women (3.5% vs. 2.2%, p < 0.05).
- •Diminishing influence of estrogen, hypercoagulability, and underprescribing in women are likely contributors to MACE.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines).Circ. Cardiovasc. Qual. Outcomes. 2017; 10e003443
- Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.J. Intern. Med. 2019; 285: 419-428
- Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study.J. Am. Heart Assoc. 2018; 7
- Impact of sex on the follow-up course and predictors of clinical outcomes in patients hospitalised due to myocardial infarction with non-obstructive coronary arteries: a single-centre experience.Kardiol. Pol. 2019; 77: 198-206
- Clinical features, sex differences and outcomes of myocardial infarction with nonobstructive coronary arteries: a registry analysis.Coron. Artery Dis. 2021; 32: 10-16
- Does sex influence outcomes in myocardial infarction with nonobstructive coronary arteries?.Angiology. 2022; 73: 275-280
- Sex-specific clinical characteristics and long-term outcomes in patients with myocardial infarction with non-obstructive coronary arteries.Front Cardiovasc Med. 2021; 8670401
- Estrogen contributions to microvascular dysfunction evolving to heart failure with preserved ejection fraction.Front. Endocrinol. (Lausanne). 2019; 10: 442
- Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease.J. Thromb. Thrombolysis. 2019; 48: 373-381
- Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): insights from a multicentre national registry.Int. J. Cardiol. 2021; 327: 9-14
- Effects of aspirin for primary prevention in persons with diabetes mellitus.N. Engl. J. Med. 2018; 379: 1529-1539
- Effect of aspirin on all-cause mortality in the healthy elderly.N. Engl. J. Med. 2018; 379: 1519-1528
- Outcome after myocardial infarction without obstructive coronary artery disease.Heart. 2019; 105: 524-530
- ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.Eur. Heart J. 2017; 38: 143-153